Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer commented on. Cramer discussed the stock’s momentum during the episode, as he said: “As of last night’s close, JNJ was the 10th best performing healthcare stock in the entire S&P 500, up 21.5% for the year. Now, if you’ve been paying attention to this one, that might come as quite a surprise. J&J still has a major litigation overhang, and more important, it’s primarily a pharmaceutical company in a market that hates pharma, or at least we though ...